Despite numerous offers from pen manufacturers to expand their selection, the company has stuck to its old-school roots. “We can’t be the best at fountain pens if we’re spread all over the ...
The latest innovations further enhance the company’s neuro and vascular portfolios. Following the news, shares of PEN inched up 0.4% to $187.65 at yesterday’s close. With thrombectomy procedures ...